Physician profile
Khoi Le
NPI 1841515913
$3,031.61
in general payments reported to CMS, 2019-2025
9 companies · $712 in 2025
The $712 reported for 2025 was more than what 76% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $106 · 2021: $122 · 2022: $234 · 2023: $646 · 2024: $1,006 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,363.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $1,216.44 | 2019-2025 | Lybalvi, Aristada, Aristada Initio |
| Janssen Pharmaceuticals, INC | $686.10 | 2023-2025 | Invega Sustenna, Invega Trinza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $501.36 | 2023-2024 | Caplyta |
| Neurocrine Biosciences, INC. | $201.41 | 2020-2024 | Ingrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.99 | 2022-2024 | Jardiance, Spiriva Respimat, Cyltezo |
| Teva Pharmaceuticals USA, INC. | $124.25 | 2024 | Uzedy |
| Otsuka America Pharmaceutical, INC. | $100.60 | 2024 | Abilify Asimtufii, Abilify Maintena |
| Abiomed | $25.64 | 2025 | |
| Amarin Pharma, INC. | $17.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khoi Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.